InfuCare Rx® is an Official Ambassador of ASPEN Malnutrition Awareness Week™

InfuCare Rx is a proud ambassador of the American Society for Parental and Enteral Nutrition (ASPEN). Malnutrition Awareness Week™ will take place September 16-24, 2024 and helps educate individuals about the identification, intervention, and treatment of malnutrition. Join us in raising awareness of malnutrition and its negative effects on patients and healthcare costs.
Read more

2023 Scholarships

We are pleased to announce the 2023 InfuCare Rx® Scholarship Program recipients! We proudly congratulate the following students: Caitlin Sorrell, Luc Chapall, Kyle Rowton, Tanisha Armstrong, Jack Law, and Elliott Janis. The annual InfuCare Rx Scholarship Program offers three categories: bleeding disorders, neuromuscular conditions, and primary immunodeficiencies. Our program offers financial support for individuals diagnosed with these chronic conditions and pursuing higher education to expand their careers and better their futures. With each passing year, we receive a significant number of qualified individuals, which makes the decision process tremendously difficult. The individuals who apply bravely battle their health challenges while dedicating time and effort to their studies. Ultimately, the students selected stood out as people who symbolize determination, courage, and the willpower to never let their condition stop them from their dreams!
Read more

Health First Infusion Business Assets Acquired by InfuCare Rx, a Leading Home Infusion Therapy Provider

Today InfuCare Rx, a leading national specialty infusion therapy provider, announced the completion of their acquisition of the business assets of Health First Infusion (HFI), a licensed home infusion pharmacy located in Florida. “The HFI asset acquisition is part of a multi-faceted plan to expand into new regions and pursue our mission of providing high-quality, cost-effective care to patients with acute and chronic health conditions,” said Deven Patel, founder and CEO of InfuCare Rx.
Read more